Clinical Trials Directory

Trials / Completed

CompletedNCT02272608

Evaluation of Sleep Apnea Related Inflammation With CRP, ESR and Neutrophil toLymphocyte Ratio

Status
Completed
Phase
Study type
Observational
Enrollment
279 (actual)
Sponsor
Ordu University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

There is some evidence suggesting that OSA is associated with low level of systemic inflammation and oxidative stress. Low level systemic inflammation and subsequent vascular damage has been implicated as the underlying mechanism responsible for comorbidities. Detection of altered inflammatory markers in OSAS patients may predict the degree of nocturnal sleep disturbance and associated systemic inflammation and presence of comorbidities. Recently, novel inflammatory biomarkers, such as neutrophil to lymphocyte ratio (NLR) have been proposed as an indicator of systemic inflammation. To our knowledge, NLR has not been studied in OSAS. We conducted the present study to evaluate the association between OSAS and inflammatory markers CRP, ESR and NLR.

Conditions

Interventions

TypeNameDescription
OTHEREvaluation of Sleep Apnea Related Inflammation with CRP, ESR and Neutrophil toLymphocyte RatioCRP, ESR and Neutrophil toLymphocyte Ratio values of sleep apnea patients were evaluated with respect to apnea- hypopnea scores.

Timeline

Start date
2012-11-01
Primary completion
2014-06-01
Completion
2014-08-01
First posted
2014-10-23
Last updated
2014-10-23

Source: ClinicalTrials.gov record NCT02272608. Inclusion in this directory is not an endorsement.

Evaluation of Sleep Apnea Related Inflammation With CRP, ESR and Neutrophil toLymphocyte Ratio (NCT02272608) · Clinical Trials Directory